Figure S5 from Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Autor:	Yan Lan, Laszlo Radvanyi, Jessie M. English, Kin-Ming Lo, Robert Tighe, Huakui Yu, Hong Wang, Jin Qi, Guozhong Qin, Bo Marelli, Giorgio Kradjian, Wilson Guzman, Vivian M. Hernández, P. Alexander Rolfe, Yanping Zhang, Chunxiao Xu
Rok vydání:	2023
DOI:	10.1158/1078-0432.22465718
Popis:	NHS-muIL12 and avelumab combination treatment enhanced the necrotic fraction in EMT-6 tumors.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5e2418003998f6f97dbd83cc9de8c7 https://doi.org/10.1158/1078-0432.22465718 Zobrazit plný text záznamu